Best Healthcare Companies in Canada
The 2418 best Healthcare companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: dentalcorp.
Canada's Healthcare sector is bigger and busier than most people realize. This directory tracks 2,418 companies across Canada, ranked by disclosed equity funding and recent funding momentum, and the total disclosed capital across those names sits at $5.3B. TerrAscend leads the field at $472M raised, with University Health Network not far behind the conversation at $107M. One unicorn has emerged from the cohort. And the gap between the top earners and the median is steep enough to tell you where investor conviction is actually concentrating.
The global picture frames it well: healthcare is forecast to hit roughly $2.6 trillion by 2025, growing at a 6.3% CAGR, driven by consumer demand for virtual touchpoints and more affordable delivery models. On the app side, median install growth across hospital and health-sciences apps is running at roughly +16% YoY, which tells you the digital front door is genuinely opening. I'd flag that vaccine development themes, from immunogenicity research to active trial pipelines, are where editorial and investor attention is visibly clustering right now. As 2018 research shows, the science underpinning those programs has matured fast. If you're sizing up where to focus, the funding concentration and the app momentum are pointing the same direction.
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
Ranked: Best Healthcare companies in Canada
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | dentalcorp Provider of continuing education and skill development services for dentists | $500M | 64 mo ago | Acquired | 8,550 | — | 10 signals ▼33% M&A · Regulatory · Earnings | — | 1 partnership |
| 2 | TerrAscend Retailer of cannabis dispensaries and medical products | $472M | 13 mo ago | Public | 36 | — | 11 signals ▼35% Earnings · Layoffs · Buyback | 5 patents Modular floating offshore platforms and containerized marine infrastructure. | 1 job opening |
| 3 | HLS Therapeutics Developer of branded pharmaceutical drugs | $350M | 84 mo ago | Public | 96 | Craig Millian CEO | 10 signals Earnings · Contracts | — | 6 job openings |
| 4 | HEXO Brand of cannabis based products 57Funding top 36%Market top 37%Talent top 39%News bottom 39% All 5 signals ▾Fundingtop 36% Markettop 37% Talenttop 39% Newsbottom 39% Globalbottom 29% Funding: Raised $246M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) Market: 689 employees (top 17% of Food and Agriculture) rank vs industry peers · Fliar Intelligence Index 57/100 | $246M | 36 mo ago | Acquired | 689 | Sebastien St-Louis Founder | — | — | — |
| 5 | Knight Therapeutics Acquires, licenses, and commercializes prescription pharmaceuticals | $244M | 87 mo ago | Public | 831 | — | 16 signals ▼41% Earnings · Announcements · Funding | — | 9 job openings |
| 6 | Flowr Provider of cannabis products | $196M | 58 mo ago | Public | — | — | — | — | — |
| 7 | Auxly Provider of platform to manage cannabis manufacturing operations in industries | $133M | 40 mo ago | Public | 420 | Ian Rapsey Co-Founder | 18 signals ▼18% Earnings · Announcements · Funding | — | 3 job openings |
| 8 | Medexus Pharmaceuticals Manufacturer of pharmaceutical drugs catering to rheumatology, immunology, and oncology among others | $123M | 44 mo ago | Public | 98 | Ken Dentremont Founder & CEO | 20 signals ▲43% Leadership · Earnings · Announcements | — | — |
| 9 | University Health Network Chain of multi-speciality hospitals | $107M | 6 mo ago | Funding Raised | 12,322 | Kevin Smith President & CEO | — | — | 1 award |
| 10 | VetCare Standalone veterinary clinic | $100M | 40 mo ago | Series D | 32 | — | — | — | 3 job openings |
| 11 | adMare BioInnovations Provider of biopharma consulting services | $92M | 50 mo ago | Funding Raised | 152 | — | — | 4 patents Small‑molecule therapeutics targeting bone formation disorders (FOP, Cyp26b1 inhibition). | 1 job opening · 1 internship · 1 expansion |
| 12 | AtomVie Provider of diversified CDMO services for radiotherapeutics | $90M | 36 mo ago | Series A | 92 | — | — | — | 5 job openings · 1 expansion |
| 13 | Green Tank Technologies Private label brand of vape products | $30M | 38 mo ago | Series B | 78 | — | — | 17 patents Design and manufacturing of industrial vaporizer units and power modules | 1 job opening · 3 launchs |
| 14 | Valeo Pharma Canadian specialty pharma company | $25M | 33 mo ago | Acquired | 121 | — | — | — | — |
| 15 | Othership Provider of immersive sauna and ice bath wellness experiences. | $21M | 12 mo ago | Series A | 46 | Robbie Bent Co-Founder & CEO | — | — | — |
| 16 | Decibel Cannabis Producer of cannabis products | $20M | 19 mo ago | Public | 171 | — | 19 signals ▼49% Earnings · Board · Funding | — | — |
| 17 | ImmunoPrecise Antibodies CDMO focused on antibody discovery and pre-clinical services | $18M | 23 mo ago | Public | 80 | Chris Buyse Board of Directors | 4 signals ▼56% Earnings · M&A | 5 patents Monoclonal antibody production and diagnostics for estrogen receptors and muscular dystrophy biomarkers | — |
| 18 | Orion Biotechnology Provider of biologic therapeutics for addressing obesity and metabolic disorders through the development of… | $16M | 13 mo ago | Series A | 21 | Mark Groper CEO | — | 3 patents Antimicrobial formulations combining octoxynol surfactants with quinolizidine alkaloids. | — |
| 19 | SRx Health Provider of patient engagement services | $15M | 7 mo ago | Series B | 67 | — | 17 signals ▲112% M&A · Lawsuit · Leadership | — | — |
| 20 | Corus Ortho Corus Orthodontists - North American Partnership | $15M | 4 mo ago | Series B | 108 | — | — | — | — |
| 21 | Algernon Pharmaceuticals Developer of small molecules for chronic kidney disease and inflammatory bowel diseases | $13M | 7 mo ago | Public | 1 | — | — | 44 patents Small-molecule drugs for liver, kidney, and CNS disorders (e.g., NASH, fibrosis, brain injury) | — |
| 22 | LSL Pharma Group Integrated pharmaceutical company provides pharma products | $13M | 9 mo ago | Public | — | Francois Roberge CEO | — | — | 2 launchs · 1 partnership |
| 23 | FUNCTIONALABGROUP Manufacturer of dermocosmetics | $12M | 14 mo ago | Series A | 12 | — | — | — | — |
| 24 | High Q Technologies Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis | $10M | 27 mo ago | Seed | 24 | Wendy Hinchey CEO | — | — | 1 job opening · 1 partnership |
| 25 | Psyched Wellness Manufacturer of wellness products | $9M | 2 mo ago | Public | 1,800 | Jeffrey Stevens CEO | — | 7 patents Therapeutic Amanita muscaria compounds, extraction methods, and delivery devices | — |
| 26 | Simply Solventless Retailer of CBD concentrates | $8M | 16 mo ago | Public | 10 | Jeffrey Swainson Founder & CEO | 10 signals ▼64% Earnings · Leadership · Announcements | — | — |
| 27 | Arch BioPartners Translates basic science research into products | $8M | 2 mo ago | Public | 17 | — | 10 signals ▲67% Leadership · Announcements · Funding | 36 patents Patents concentrated in health & consumer products | 1 partnership |
| 28 | Sirona Biochem Developer of therapeutics for the treatment of skincare | $7M | 13 mo ago | Public | 11 | Howard Verrico CEO | — | — | — |
| 29 | Twig Fertility Online platform offering multiple services for fertility care | $6M | 16 mo ago | Series A | 27 | Tanner Kohara Co-Founder | — | — | — |
| 30 | Britannia Life Sciences Research lab providing product development, QA, safety, and regulatory compliance services | $5M | 18 mo ago | Public | 5 | Peter Shippen Chief Executive Officer | — | — | — |
| 31 | RI-MUHC Provider of cloud-based accounting and payroll solutions | $5M | 11 mo ago | Funding Raised | 720 | — | — | — | 1 job opening · 2 awards |
| 32 | Optimi Health Manufacturer of vegan protein | $4M | 11 mo ago | Public | — | Bill Ciprick Chief Executive Officer | — | — | 4 launchs · 1 expansion |
| 33 | Voyageur Pharmaceuticals Manufacturer of barium and iodine generic radiographic drugs | $4M | 16 mo ago | Public | — | Brent Willis CEO & Director | — | — | — |
| 34 | KDA Provider of digital and artificial intelligence solutions, specialized medical education and training, and… | $2M | 12 mo ago | Public | — | Marc Lemieux CEO | — | — | — |
| 35 | Arbutus Medical Manufacturer of orthopedic surgical tools and devices | $2M | 14 mo ago | Seed | 25 | Michael Cancilla Sr. Director of Product | — | 20 patents Orthopedic traction pin systems for bone fixation and surgical device components | — |
| 36 | Molecule Brand of cannabis infused beverage products | $2M | 18 mo ago | Acquired | 13 | Andre Audet Co-Founder | — | 2 patents Child‑proof sealing mechanisms for beverage containers | — |
| 37 | CHUSJ Provider of mother-child healthcare services and research | $2M | 14 mo ago | Funding Raised | 2,581 | — | — | — | 1 job opening |
| 38 | Lumiera Health Innovation Manufacturer of natural healthcare products | $2M | 16 mo ago | Acquired | — | Kevin Roland CEO | — | — | — |
| 39 | The BC Bud Co Provider of cannabis cultivators services | $2M | 16 mo ago | Public | 6 | TJ Taylor Co-Founder | — | — | — |
| 40 | Medigroup Health Services Network of medical clinics, pharmacies, and home care services provider | $2M | 16 mo ago | Seed | 31 | — | — | — | — |
| 41 | MTL Cannabis Manufacturer and distributor of medical cannabis products | $1M | 8 mo ago | Acquired | — | Mitch Co-Founder | 18 signals ▲29% M&A · Earnings · Funding | — | — |
| 42 | Andira Digital pharmacotherapeutic platform for providers 21Funding top 50%Talent bottom 49%Market bottom 37%Global bottom 29% All 4 signals ▾Fundingtop 50% Talentbottom 49% Marketbottom 37% Globalbottom 29% Funding: Raised $1.4M across 5 rounds · 5 rounds over 4 yrs (1.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $1M | 3 mo ago | Seed | — | Dana Lambert Chief Executive Officer | — | — | — |
| 43 | UniDoc Health Provider of tele healthcare services | $1M | 7 mo ago | Public | — | Antonio Baldassarre CEO | 6 signals ▼50% Funding · Earnings | — | — |
| 44 | Christina Lake Cannabis Provider of sun-grown cannabis flower, oil cannabinoids, hemp-based extracts, and derivatives 19Funding top 44%Tech top 50%Talent bottom 49%Market bottom 25% All 6 signals ▾Fundingtop 44% Techtop 50% Talentbottom 49% Marketbottom 25% Globalbottom 25% Newsbottom 22% Funding: Raised $1.4M across 9 rounds · 9 rounds over 6 yrs (1.5/yr) Tech: 25 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 19/100 | $1M | 13 mo ago | Public | 12 | Mark Aiken CEO | — | — | — |
| 45 | Allied Health Medical cannabis supplier delivering pharmaceutical-grade solutions worldwide 11Funding top 44%Talent bottom 49%Market bottom 34%Growth bottom 32% All 6 signals ▾Fundingtop 44% Talentbottom 49% Marketbottom 34% Growthbottom 32% Globalbottom 30% Fin. healthbottom 15% Funding: Raised $1.4M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 11/100 | $1M | 19 mo ago | Public | 165 | Calum Hughes Founder & CEO | — | — | — |
| 46 | Dentronic Developer of robotic arm designed to automate dental assistive tasks 50Talent top 45%Global bottom 48%Funding bottom 47% All 3 signals ▾Talenttop 45% Globalbottom 48% Fundingbottom 47% Talent: 2 named leaders on record Global: Investors from 1 country beyond Canada rank vs industry peers · Fliar Intelligence Index 50/100 | $1M | 3 mo ago | Seed | — | Soy Choi Co-Founder | — | — | — |
| 47 | Myomar Molecular Provider of healthcare technology services | $810K | 1 mo ago | Seed | 3 | — | — | 4 patents Muscle atrophy biomarkers for diagnostic and therapeutic applications | — |
| 48 | Cizzle Brands Health and wellness company offering hydration and nutrition products 35Growth top 37%Funding top 42%Talent bottom 49%Tech bottom 46% All 6 signals ▾Growthtop 37% Fundingtop 42% Talentbottom 49% Techbottom 46% Globalbottom 36% Marketbottom 22% Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo Funding: Raised $787k across 6 rounds · 6 rounds over 2 yrs (3.0/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $787K | 1 mo ago | Public | — | John Celenza Founder & CEO | — | — | 1 launch · 1 expansion |
| 49 | Ring Rescue Manufacturer of air pressure measurement device to reduce finger swelling | $570K | 16 mo ago | Seed | 15 | Kevin Spencer Founder | — | 22 patents Emergency medical devices for cutting and removing rings trapped on digits | 1 launch |
| 50 | CanadaBis M&A advisory firm focused on the cannabis industry | $473K | 5 mo ago | Public | — | Travis McIntyre President | — | — | — |
Top 12 Healthcare companies in Canada
#1
Funding Raised · Toronto, Ontario · founded 1998 · 12322 employees$107.1Mraised▾
Chain of multi-speciality hospitals
- Dec 2025Grant (prize money)$4.5M
- May 2025Grant (prize money)$16.4M
- Apr 2025Grant (prize money)$1.8M
- Apr 2025Grant (prize money)$1.2M
#2
Public · Mississauga, Ontario · founded 2017 · 36 employees$471.8Mraised▾
Retailer of cannabis dispensaries and medical products
- May 2025Post IPO$1.3M
- Jun 2023Post IPO$20.5M
- Jan 2021Post IPO$175.4M
- Jun 2020Post IPO$19.6M
#3
Public · Toronto, Ontario · founded 1983 · 17 employees$7.6Mraised▾
Arch Biopartners business model is based on working closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors. Arch has established a diverse portfolio that includes MetaMx (synthetic peptides that target and attach to BTICs and invasive glioma cells), which targets illusive brain tumor-initiating cells; AB569 (inhalable small molecule), a potential new treatment for Pseudomonas aeruginosa pulmonary infections; and, Metablok, a potential treatment for sepsis and cancer metastasis. MetaMx and AB569 are both on track to enter human clinical trials in late 2016 or early 2017.
- Mar 2026Post IPO$431.8K
- Nov 2025Post IPO$427.1K
- Mar 2025Post IPO$261.7K
- Mar 2025Post IPO$241.9K
#4
Public · Toronto, Ontario · founded 2019 · 1800 employees$8.7Mraised▾
Manufacturer of wellness products
- Mar 2026Post IPO$626K
- Apr 2024Post IPO$2.5M
- May 2023Post IPO$500K
- Feb 2021Post IPO$731.6K
#5
Series B · Canada · founded 2019 · 108 employees$14.7Mraised▾
Are you an Orthodontist seeking a different type of partnership than the traditional DSO? Learn more about Corus today!
- Feb 2026Series B$14.7M
#6
Public · Vancouver, British Columbia · founded 2015 · 1 employees$12.8Mraised▾
Algernon Pharmaceuticals is a developer of small molecules for chronic kidney disease and inflammatory bowel diseases. The company is using a drug repurposing strategy to discover drugs. The lead candidate, NP-135 is an antifibrotic compound being investigated for NASH (phase 1). Other molecules are in phase 1 trials for CKD and IBD.
- Nov 2025Post IPO$607.7K
- May 2025Post IPO$554.6K
- Jul 2024Post IPO$299.4K
- Apr 2024Post IPO$12.6K
#7
Series B · Toronto, Ontario · founded 2013 · 67 employees$15.2Mraised▾
Provider of patient engagement services
- Oct 2025Series B$15.2M
#8
Public · Boucherville, Quebec · founded 2023$12.6Mraised▾
Groupe LSL Pharma is a Canadian integrated pharmaceutical company that focuses on innovation in life science products to support the Canadian population. They have recently announced new orders with an annual revenue potential exceeding $2.6 million.
- Sep 2025Post IPO$1.7M
- Dec 2024Post IPO—
- Jul 2024Post IPO$960K
- Jun 2024Post IPO$1.1M
#9
Public · Toronto, Ontario · founded 2024$787.5Kraised▾
Cizzle Brands is a company dedicated to elevating the game in health and wellness, offering innovative hydration solutions for athletes and individuals alike. They aim to help individuals achieve their full potential through their products and services.
- May 2026Post IPO$6.2M
- Jul 2025Post IPO$712.3K
- Jan 2025Post IPO$98.7K
- Dec 2024Seed$42.1K
#10
Seed · Halifax, Nova Scotia · founded 2021 · 3 employees$810.2Kraised▾
Provider of healthcare technology services
- May 2026Seed$365.5K
- Mar 2024Seed$810.2K
- 2023Grant (prize money)$50K
#11
Seed · Vancouver, British Columbia · founded 2020$1.4Mraised▾
Digital pharmacotherapeutic platform for providers. It is a platform for the discovery and creation of natural chemicals with the potential for medicinal usage.
- Feb 2026Seed$152.4K
- Aug 2024Seed$809.9K
- Jun 2024Seed$18.3K
- Oct 2023Seed$212K
#12
Series A · Toronto, Ontario · founded 2020 · 46 employees$20.6Mraised▾
{}
- May 2025Series A$11.3M
- Jan 2023Series A$8M
- 2020Seed$1.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising